Algert Global’s Jazz Pharmaceuticals JAZZ Stock Holding History

Algert Global’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.93M	Hold	52,520	–	–	0.15%	206
2025 Q4	$8.93M	Buy	+52,520	New	+$8.05M	0.14%	247
2025 Q1	–	Sell	-13,655	Closed	-$1.68M	–	1259
2024 Q4	$1.68M	Buy	+13,655	New	+$1.61M	0.04%	664
2024 Q3	–	Sell	-5,964	Closed	-$637K	–	1378
2024 Q2	$637K	Buy	+5,964	New	+$656K	0.02%	818
2023 Q2	–	Sell	-8,959	Closed	-$1.31M	–	1166
2023 Q1	$1.31M	Buy	+8,959	New	+$1.33M	0.06%	521
2020 Q4	–	Sell	-23,218	Closed	-$3.31M	–	449
2020 Q3	$3.31M	Buy	+23,218	New	+$2.88M	1.05%	5
2016 Q4	–	Sell	-9,108	Closed	-$1.11M	–	373
2016 Q3	$1.11M	Buy	9,108 +7,397	+432%	+$997K	0.32%	124
2016 Q2	$242K	Sell	1,711 -7,873	-82%	-$1.16M	0.1%	297
2016 Q1	$1.25M	Buy	9,584 +1,254	+15%	+$156K	0.47%	59
2015 Q4	$1.17M	Buy	+8,330	New	+$1.15M	0.55%	52

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Algert Global's JAZZ Position: Q1 2026 in Review

Algert Global held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 52,520 shares worth $9.93M. The position accounts for 0.15% of the portfolio, ranked #206.

Algert Global first reported a position in JAZZ in Q4 2015 and has held it in 10 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Algert Global held 52,520 shares of Jazz Pharmaceuticals worth $9.93M as of Q1 2026.
Algert Global left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up 0.15% of Algert Global's portfolio in Q1 2026, its #206 holding.
Algert Global first reported a position in Jazz Pharmaceuticals in Q4 2015 and has held it in 10 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.